Why the study?
To assess sex-specific time-associated changes in the impact of risk factors on coronary artery disease mortality in a general population over long-term follow-up.
Cohort (n=8,396)
Yes
Hazard Ratio: 2.3 (95% CI 1.37–3.85)
The predictive value of specific cardiovascular risk factors for CAD mortality changes over time, with smoking and cholesterol having early impacts while diabetes and systolic blood pressure show stronger long-term effects.
BACKGROUND: This study assessed sex-specific time-associated changes in the impact of risk factors on coronary artery disease (CAD) mortality in a general population over long-term follow-up. METHODS AND RESULTS: A prospective longitudinal cohort study was conducted on representative Japanese populations followed up for 29 years. Data from 8,396 participants (3,745 men, 4,651 women) were analyzed. The sex-specific multivariable adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of 4 risk factors (smoking, diabetes, serum total cholesterol [TC], and systolic blood pressure [SBP]) for CAD mortality were calculated at baseline and at 10, 15, 20, 25, and 29 years of follow-up. In men, smoking (HR 3.23; 95% CI 1.16-9.02) and a 1-SD increase in TC (HR 1.82; 95% CI 1.29-2.57) were strongly associated with a higher risk of CAD in the first 10 years, but this association decreased over time. Diabetes (HR 2.30; 95% CI 1.37-3.85) and a 1-SD increase in SBP (HR 1.23; 95% CI 1.00-1.50) were strongly correlated with a higher risk of CAD after 29 years). In women, diabetes was correlated with CAD after 20 years (HR 2.53; 95% CI 1.19-5.36) and this correlation persisted until after 29 years (HR 2.47; 95% CI 1.40-4.35). CONCLUSIONS: The duration of follow-up needed for the accurate assessment of risk factors for CAD mortality varies according to risk factor and sex.
No takes yet. Share an insight, caveat, or question.
Okami et al. (2020) conducted a cohort in Coronary artery disease (CAD) mortality (n=8,396). Diabetes vs. Non-diabetes was evaluated on Coronary artery disease (CAD) mortality at 29 years (in men) (HR 2.30, 95% CI 1.37-3.85).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: